Dipartimento di Chimica e Biologia "A. Zambelli", Università di Salerno, Via Giovanni Paolo II, 84084 Fisciano, Italy.
J Org Chem. 2023 Jun 16;88(12):7888-7892. doi: 10.1021/acs.joc.2c02491. Epub 2023 Feb 21.
A one-pot Knoevenagel reaction/asymmetric epoxidation/domino ring-opening cyclization (DROC) has been developed from commercial aldehydes, (phenylsulfonyl)acetonitrile, cumyl hydroperoxide, 1,2-ethylendiamines, and 1,2-ethanol amines to provide 3-aryl/alkyl piperazin-2-ones and morpholin-2-ones in yields of 38 to 90% and up to 99% ee. Two out of the three steps are stereoselectively catalyzed by a quinine derived urea. The sequence has been applied for a short enantioselective entry to a key intermediate, in both absolute configurations, involved in the synthesis of the potent antiemetic drug Aprepitant.
一锅法 Knoevenagel 反应/不对称环氧化/多米诺开环环化(DROC)已从商业醛、(苯磺酰)乙腈、过氧化枯烯、1,2-乙二胺和 1,2-乙醇胺发展而来,以提供 3-芳基/烷基哌嗪-2-酮和吗啉-2-酮,产率为 38%至 90%,ee 值高达 99%。三步中有两步由奎宁衍生的脲立体选择性催化。该序列已应用于一种关键中间体的短对映选择性入口,该中间体涉及强效止吐药阿瑞匹坦的合成,具有两种绝对构型。